Skip to main content
Message Font: Serif | Sans-Serif
 
No. of Recommendations: 0
This morning's news:

Vertex gives $900m to CRSPR for a 60% stake in sickle cell tx.

Bluebird says commercialization is a tough landscape since payors won't cover it. Lays off a bunch of people.


Take home:
Gene therapy is a minefield.

This does not bode well for editas.
Print the post  

Announcements

What was Your Dumbest Investment?
Share it with us -- and learn from others' stories of flubs.
When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.